Transform your network of family, friends, and employees with our new at-home weight loss treatment program! A healthy person is a productive person, and with almost 40% of Americans facing obesity or severe obesity today, it's time to promote healthy living. Our program offers a convenient and effective solution for people to achieve their weight loss goals from the comfort of their own homes. Plus, with a 100% FREE online medical consultation, getting started is easier than ever. Take the first step towards a healthier, happier workforce today!
Choose from injectable, sublingual troches, or capsules, starting at just $149. With options to suit every individual, our range of treatments ensures effective and personalized weight loss solutions, all of which are HSA and FSA approved. Invest in your employees' health and well-being today!
Get your medications delivered to your door from a licensed pharmacy, serving all 50 states. Your employees deserve convenient and reliable access to the medications they need. Trust us to deliver quality care right to their doorstep.
Healthy employees, healthy company. Weight loss can boost productivity, reduce healthcare costs, and improve morale. Invest in your team's well-being and watch your business thrive.
"Excess body weight: Novel insights into its roles in obesity comorbidities"
Abstract: Excess body weight is a global health problem due to sedentary lifestyle and unhealthy diet, affecting 2 billion population worldwide. Obesity is a major risk factor for metabolic diseases. Notably, the metabolic risk of obesity largely depends on body weight distribution, of which visceral adipose tissues but not subcutaneous fats are closely associated with obesity comorbidities, including type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and certain types of cancer....
"Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes:
A Systematic Review and Meta-Analysis"
Conclusion: Among individuals with obesity without type 2 diabetes, subcutaneous semaglutide is effective for weight loss with an 11.85% reduction from baseline compared to placebo. This supports the use of semaglutide for weight management in obesity. However, risk of gastrointestinal adverse events, discontinuation of treatment and serious adverse events were higher in the semaglutide group versus placebo.
